SEC Form 4 · accession 0001209191-17-008724
ACURA PHARMACEUTICALS, INC · ACUR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert A Seiser
Officer — VP, Controller & Treasurer
Period of report
Feb 7, 2017
Accepted (ET)
Feb 8, 2017 · 5:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000786947
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 7, 2017 | M | 1,166 | $0.915 | A | 23,311 | D | |
| Common StockF1 | Feb 7, 2017 | F | 821 | $1.30 | D | 22,490 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF4,F2,F3 | $0.915 | Feb 7, 2017 | M | 1,166 | D | — | Dec 7, 2026 | Common Stock | 1,166 | 12,384 | D |
Explanation of responses
- F1Represents payment for exercise price
- F2Exercise price is closing price of Issuer's common stock on December 8, 2016.
- F3one-twenty-fourth of shares underlying options vest and are exercisable on the last day of each month commencing December 31, 2016 and ending on November 30, 2018. Option vesting and exercisability is accelerated upon a qualifying change of control.
- F4Not Applicable.